0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic Analgesics Market Research Report 2026
Published Date: 2026-02-25
|
Report Code: QYRE-Auto-18O9126
Home | Market Reports
Global Antipyretic Analgesics Market Outlook 2022
BUY CHAPTERS

Global Antipyretic Analgesics Market Research Report 2026

Code: QYRE-Auto-18O9126
Report
2026-02-25
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic Analgesics Market Size

The global Antipyretic Analgesics market was valued at US$ 2879 million in 2025 and is anticipated to reach US$ 3126 million by 2032, at a CAGR of 1.2% from 2026 to 2032.

Antipyretic Analgesics Market

Antipyretic Analgesics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antipyretic Analgesics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world"s main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
This report delivers a comprehensive overview of the global Antipyretic Analgesics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antipyretic Analgesics. The Antipyretic Analgesics market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antipyretic Analgesics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Antipyretic Analgesics Market Report

Report Metric Details
Report Name Antipyretic Analgesics Market
Accounted market size in 2025 US$ 2879 million
Forecasted market size in 2032 US$ 3126 million
CAGR 1.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Oxaprozin
  • Dexibuprofen
  • Others
by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hebei Jingye Medical Technology, MSPF
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Antipyretic Analgesics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Antipyretic Analgesics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Antipyretic Analgesics Market growing?

Ans: The Antipyretic Analgesics Market witnessing a CAGR of 1.2% during the forecast period 2026-2032.

What is the Antipyretic Analgesics Market size in 2032?

Ans: The Antipyretic Analgesics Market size in 2032 will be US$ 3126 million.

Who are the main players in the Antipyretic Analgesics Market report?

Ans: The main players in the Antipyretic Analgesics Market are Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hebei Jingye Medical Technology, MSPF

What are the Application segmentation covered in the Antipyretic Analgesics Market report?

Ans: The Applications covered in the Antipyretic Analgesics Market report are Adults, Children

What are the Type segmentation covered in the Antipyretic Analgesics Market report?

Ans: The Types covered in the Antipyretic Analgesics Market report are Paracetamol, Aspirin, Ibuprofen, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others

1 Antipyretic Analgesics Market Overview
1.1 Product Definition
1.2 Antipyretic Analgesics by Type
1.2.1 Global Antipyretic Analgesics Market Value by Type: 2025 vs 2032
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Antipyretic Analgesics by Application
1.3.1 Global Antipyretic Analgesics Market Value by Application: 2025 vs 2032
1.3.2 Adults
1.3.3 Children
1.4 Global Antipyretic Analgesics Market Size Estimates and Forecasts
1.4.1 Global Antipyretic Analgesics Revenue 2021–2032
1.4.2 Global Antipyretic Analgesics Sales 2021–2032
1.4.3 Global Antipyretic Analgesics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antipyretic Analgesics Market Competition by Manufacturers
2.1 Global Antipyretic Analgesics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antipyretic Analgesics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antipyretic Analgesics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antipyretic Analgesics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antipyretic Analgesics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antipyretic Analgesics, Product Types and Applications
2.7 Global Key Manufacturers of Antipyretic Analgesics, Date of Entry into the Industry
2.8 Global Antipyretic Analgesics Market Competitive Situation and Trends
2.8.1 Global Antipyretic Analgesics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antipyretic Analgesics Players Market Share by Revenue
2.8.3 Global Antipyretic Analgesics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antipyretic Analgesics Market Scenario by Region
3.1 Global Antipyretic Analgesics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antipyretic Analgesics Sales by Region: 2021–2032
3.2.1 Global Antipyretic Analgesics Sales by Region: 2021–2026
3.2.2 Global Antipyretic Analgesics Sales by Region: 2027–2032
3.3 Global Antipyretic Analgesics Revenue by Region: 2021–2032
3.3.1 Global Antipyretic Analgesics Revenue by Region: 2021–2026
3.3.2 Global Antipyretic Analgesics Revenue by Region: 2027–2032
3.4 North America Antipyretic Analgesics Market Facts & Figures by Country
3.4.1 North America Antipyretic Analgesics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antipyretic Analgesics Sales by Country (2021–2032)
3.4.3 North America Antipyretic Analgesics Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antipyretic Analgesics Market Facts & Figures by Country
3.5.1 Europe Antipyretic Analgesics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antipyretic Analgesics Sales by Country (2021–2032)
3.5.3 Europe Antipyretic Analgesics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic Analgesics Market Facts & Figures by Region
3.6.1 Asia Pacific Antipyretic Analgesics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antipyretic Analgesics Sales by Region (2021–2032)
3.6.3 Asia Pacific Antipyretic Analgesics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antipyretic Analgesics Market Facts & Figures by Country
3.7.1 Latin America Antipyretic Analgesics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antipyretic Analgesics Sales by Country (2021–2032)
3.7.3 Latin America Antipyretic Analgesics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic Analgesics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antipyretic Analgesics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic Analgesics Sales by Type (2021–2032)
4.1.1 Global Antipyretic Analgesics Sales by Type (2021–2026)
4.1.2 Global Antipyretic Analgesics Sales by Type (2027–2032)
4.1.3 Global Antipyretic Analgesics Sales Market Share by Type (2021–2032)
4.2 Global Antipyretic Analgesics Revenue by Type (2021–2032)
4.2.1 Global Antipyretic Analgesics Revenue by Type (2021–2026)
4.2.2 Global Antipyretic Analgesics Revenue by Type (2027–2032)
4.2.3 Global Antipyretic Analgesics Revenue Market Share by Type (2021–2032)
4.3 Global Antipyretic Analgesics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antipyretic Analgesics Sales by Application (2021–2032)
5.1.1 Global Antipyretic Analgesics Sales by Application (2021–2026)
5.1.2 Global Antipyretic Analgesics Sales by Application (2027–2032)
5.1.3 Global Antipyretic Analgesics Sales Market Share by Application (2021–2032)
5.2 Global Antipyretic Analgesics Revenue by Application (2021–2032)
5.2.1 Global Antipyretic Analgesics Revenue by Application (2021–2026)
5.2.2 Global Antipyretic Analgesics Revenue by Application (2027–2032)
5.2.3 Global Antipyretic Analgesics Revenue Market Share by Application (2021–2032)
5.3 Global Antipyretic Analgesics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Company Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 IOL
6.2.1 IOL Company Information
6.2.2 IOL Description and Business Overview
6.2.3 IOL Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 IOL Antipyretic Analgesics Product Portfolio
6.2.5 IOL Recent Developments/Updates
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Company Information
6.3.2 Anqiu Lu'an Pharmaceutical Description and Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
6.4 Novacyl
6.4.1 Novacyl Company Information
6.4.2 Novacyl Description and Business Overview
6.4.3 Novacyl Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novacyl Antipyretic Analgesics Product Portfolio
6.4.5 Novacyl Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BASF Antipyretic Analgesics Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Company Information
6.6.2 Anhui BBCA Pharmaceuticals Description and Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
6.7 Hubei Biocause
6.7.1 Hubei Biocause Company Information
6.7.2 Hubei Biocause Description and Business Overview
6.7.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
6.7.5 Hubei Biocause Recent Developments/Updates
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Company Information
6.8.2 Xinhua Pharm Description and Business Overview
6.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
6.8.5 Xinhua Pharm Recent Developments/Updates
6.9 Granules India Limited
6.9.1 Granules India Limited Company Information
6.9.2 Granules India Limited Description and Business Overview
6.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
6.9.5 Granules India Limited Recent Developments/Updates
6.10 Huagang Pharm
6.10.1 Huagang Pharm Company Information
6.10.2 Huagang Pharm Description and Business Overview
6.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
6.10.5 Huagang Pharm Recent Developments/Updates
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Company Information
6.11.2 Hebei Jiheng Pharmaceutical Description and Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Company Information
6.12.2 Zhejiang Kangle Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Company Information
6.13.2 Hebei Jingye Medical Technology Description and Business Overview
6.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
6.14 MSPF
6.14.1 MSPF Company Information
6.14.2 MSPF Description and Business Overview
6.14.3 MSPF Antipyretic Analgesics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 MSPF Antipyretic Analgesics Product Portfolio
6.14.5 MSPF Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic Analgesics Industry Chain Analysis
7.2 Antipyretic Analgesics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic Analgesics Production Mode & Process Analysis
7.4 Antipyretic Analgesics Sales and Marketing
7.4.1 Antipyretic Analgesics Sales Channels
7.4.2 Antipyretic Analgesics Distributors
7.5 Antipyretic Analgesics Customer Analysis
8 Antipyretic Analgesics Market Dynamics
8.1 Antipyretic Analgesics Industry Trends
8.2 Antipyretic Analgesics Market Drivers
8.3 Antipyretic Analgesics Market Challenges
8.4 Antipyretic Analgesics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antipyretic Analgesics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Antipyretic Analgesics Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Antipyretic Analgesics Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Antipyretic Analgesics Sales (MT) of Key Manufacturers (2021–2026)
 Table 5. Global Antipyretic Analgesics Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Antipyretic Analgesics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Antipyretic Analgesics Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Antipyretic Analgesics Average Price (USD/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Antipyretic Analgesics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Antipyretic Analgesics, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Antipyretic Analgesics, Product Types and Applications
 Table 12. Global Key Manufacturers of Antipyretic Analgesics, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antipyretic Analgesics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic Analgesics Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Antipyretic Analgesics Sales by Region (MT), 2021–2026
 Table 18. Global Antipyretic Analgesics Sales Market Share by Region (2021–2026)
 Table 19. Global Antipyretic Analgesics Sales by Region (MT), 2027–2032
 Table 20. Global Antipyretic Analgesics Sales Market Share by Region (2027–2032)
 Table 21. Global Antipyretic Analgesics Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Antipyretic Analgesics Revenue Market Share by Region (2021–2026)
 Table 23. Global Antipyretic Analgesics Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Antipyretic Analgesics Revenue Market Share by Region (2027–2032)
 Table 25. North America Antipyretic Analgesics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Antipyretic Analgesics Sales by Country (MT), 2021–2026
 Table 27. North America Antipyretic Analgesics Sales by Country (MT), 2027–2032
 Table 28. North America Antipyretic Analgesics Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Antipyretic Analgesics Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Antipyretic Analgesics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Antipyretic Analgesics Sales by Country (MT), 2021–2026
 Table 32. Europe Antipyretic Analgesics Sales by Country (MT), 2027–2032
 Table 33. Europe Antipyretic Analgesics Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Antipyretic Analgesics Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Antipyretic Analgesics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Antipyretic Analgesics Sales by Region (MT), 2021–2026
 Table 37. Asia Pacific Antipyretic Analgesics Sales by Region (MT), 2027–2032
 Table 38. Asia Pacific Antipyretic Analgesics Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Antipyretic Analgesics Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Antipyretic Analgesics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Antipyretic Analgesics Sales by Country (MT), 2021–2026
 Table 42. Latin America Antipyretic Analgesics Sales by Country (MT), 2027–2032
 Table 43. Latin America Antipyretic Analgesics Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Antipyretic Analgesics Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Antipyretic Analgesics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Antipyretic Analgesics Sales by Country (MT), 2021–2026
 Table 47. Middle East and Africa Antipyretic Analgesics Sales by Country (MT), 2027–2032
 Table 48. Middle East and Africa Antipyretic Analgesics Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Antipyretic Analgesics Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Antipyretic Analgesics Sales (MT) by Type (2021–2026)
 Table 51. Global Antipyretic Analgesics Sales (MT) by Type (2027–2032)
 Table 52. Global Antipyretic Analgesics Sales Market Share by Type (2021–2026)
 Table 53. Global Antipyretic Analgesics Sales Market Share by Type (2027–2032)
 Table 54. Global Antipyretic Analgesics Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Antipyretic Analgesics Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Antipyretic Analgesics Revenue Market Share by Type (2021–2026)
 Table 57. Global Antipyretic Analgesics Revenue Market Share by Type (2027–2032)
 Table 58. Global Antipyretic Analgesics Price (USD/Kg) by Type (2021–2026)
 Table 59. Global Antipyretic Analgesics Price (USD/Kg) by Type (2027–2032)
 Table 60. Global Antipyretic Analgesics Sales (MT) by Application (2021–2026)
 Table 61. Global Antipyretic Analgesics Sales (MT) by Application (2027–2032)
 Table 62. Global Antipyretic Analgesics Sales Market Share by Application (2021–2026)
 Table 63. Global Antipyretic Analgesics Sales Market Share by Application (2027–2032)
 Table 64. Global Antipyretic Analgesics Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Antipyretic Analgesics Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Antipyretic Analgesics Revenue Market Share by Application (2021–2026)
 Table 67. Global Antipyretic Analgesics Revenue Market Share by Application (2027–2032)
 Table 68. Global Antipyretic Analgesics Price (USD/Kg) by Application (2021–2026)
 Table 69. Global Antipyretic Analgesics Price (USD/Kg) by Application (2027–2032)
 Table 70. Mallinckrodt Pharmaceuticals Company Information
 Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 72. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 73. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product
 Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 75. IOL Company Information
 Table 76. IOL Description and Business Overview
 Table 77. IOL Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 78. IOL Antipyretic Analgesics Product
 Table 79. IOL Recent Developments/Updates
 Table 80. Anqiu Lu'an Pharmaceutical Company Information
 Table 81. Anqiu Lu'an Pharmaceutical Description and Business Overview
 Table 82. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 83. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product
 Table 84. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
 Table 85. Novacyl Company Information
 Table 86. Novacyl Description and Business Overview
 Table 87. Novacyl Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 88. Novacyl Antipyretic Analgesics Product
 Table 89. Novacyl Recent Developments/Updates
 Table 90. BASF Company Information
 Table 91. BASF Description and Business Overview
 Table 92. BASF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 93. BASF Antipyretic Analgesics Product
 Table 94. BASF Recent Developments/Updates
 Table 95. Anhui BBCA Pharmaceuticals Company Information
 Table 96. Anhui BBCA Pharmaceuticals Description and Business Overview
 Table 97. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 98. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product
 Table 99. Anhui BBCA Pharmaceuticals Recent Developments/Updates
 Table 100. Hubei Biocause Company Information
 Table 101. Hubei Biocause Description and Business Overview
 Table 102. Hubei Biocause Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 103. Hubei Biocause Antipyretic Analgesics Product
 Table 104. Hubei Biocause Recent Developments/Updates
 Table 105. Xinhua Pharm Company Information
 Table 106. Xinhua Pharm Description and Business Overview
 Table 107. Xinhua Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 108. Xinhua Pharm Antipyretic Analgesics Product
 Table 109. Xinhua Pharm Recent Developments/Updates
 Table 110. Granules India Limited Company Information
 Table 111. Granules India Limited Description and Business Overview
 Table 112. Granules India Limited Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 113. Granules India Limited Antipyretic Analgesics Product
 Table 114. Granules India Limited Recent Developments/Updates
 Table 115. Huagang Pharm Company Information
 Table 116. Huagang Pharm Description and Business Overview
 Table 117. Huagang Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 118. Huagang Pharm Antipyretic Analgesics Product
 Table 119. Huagang Pharm Recent Developments/Updates
 Table 120. Hebei Jiheng Pharmaceutical Company Information
 Table 121. Hebei Jiheng Pharmaceutical Description and Business Overview
 Table 122. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 123. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product
 Table 124. Hebei Jiheng Pharmaceutical Recent Developments/Updates
 Table 125. Zhejiang Kangle Pharmaceutical Company Information
 Table 126. Zhejiang Kangle Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 128. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product
 Table 129. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
 Table 130. Hebei Jingye Medical Technology Company Information
 Table 131. Hebei Jingye Medical Technology Description and Business Overview
 Table 132. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 133. Hebei Jingye Medical Technology Antipyretic Analgesics Product
 Table 134. Hebei Jingye Medical Technology Recent Developments/Updates
 Table 135. MSPF Company Information
 Table 136. MSPF Description and Business Overview
 Table 137. MSPF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 138. MSPF Antipyretic Analgesics Product
 Table 139. MSPF Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Antipyretic Analgesics Distributors List
 Table 143. Antipyretic Analgesics Customers List
 Table 144. Antipyretic Analgesics Market Trends
 Table 145. Antipyretic Analgesics Market Drivers
 Table 146. Antipyretic Analgesics Market Challenges
 Table 147. Antipyretic Analgesics Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antipyretic Analgesics
 Figure 2. Global Antipyretic Analgesics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Antipyretic Analgesics Market Share by Type: 2025 & 2032
 Figure 4. Paracetamol Product Picture
 Figure 5. Aspirin Product Picture
 Figure 6. Ibuprofen Product Picture
 Figure 7. Naproxen Product Picture
 Figure 8. Diclofenac Product Picture
 Figure 9. Oxaprozin Product Picture
 Figure 10. Dexibuprofen Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Antipyretic Analgesics Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Antipyretic Analgesics Market Share by Application: 2025 & 2032
 Figure 14. Adults
 Figure 15. Children
 Figure 16. Global Antipyretic Analgesics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Antipyretic Analgesics Market Size (US$ Million), 2021–2032
 Figure 18. Global Antipyretic Analgesics Sales (MT), 2021–2032
 Figure 19. Global Antipyretic Analgesics Average Price (USD/Kg), 2021–2032
 Figure 20. Antipyretic Analgesics Report Years Considered
 Figure 21. Antipyretic Analgesics Sales Share by Manufacturers in 2025
 Figure 22. Global Antipyretic Analgesics Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Antipyretic Analgesics Players: Market Share by Revenue in Antipyretic Analgesics in 2025
 Figure 24. Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Antipyretic Analgesics Sales Market Share by Country (2021–2032)
 Figure 27. North America Antipyretic Analgesics Revenue Market Share by Country (2021–2032)
 Figure 28. U.S. Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Antipyretic Analgesics Sales Market Share by Country (2021–2032)
 Figure 31. Europe Antipyretic Analgesics Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Antipyretic Analgesics Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Antipyretic Analgesics Revenue Market Share by Region (2021–2032)
 Figure 39. China Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Taiwan Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Indonesia Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Thailand Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Malaysia Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Philippines Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Latin America Antipyretic Analgesics Sales Market Share by Country (2021–2032)
 Figure 50. Latin America Antipyretic Analgesics Revenue Market Share by Country (2021–2032)
 Figure 51. Mexico Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Brazil Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Argentina Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Middle East and Africa Antipyretic Analgesics Sales Market Share by Country (2021–2032)
 Figure 55. Middle East and Africa Antipyretic Analgesics Revenue Market Share by Country (2021–2032)
 Figure 56. Turkey Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Saudi Arabia Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. UAE Antipyretic Analgesics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Global Sales Market Share of Antipyretic Analgesics by Type (2021–2032)
 Figure 60. Global Revenue Market Share of Antipyretic Analgesics by Type (2021–2032)
 Figure 61. Global Antipyretic Analgesics Price (USD/Kg) by Type (2021–2032)
 Figure 62. Global Sales Market Share of Antipyretic Analgesics by Application (2021–2032)
 Figure 63. Global Revenue Market Share of Antipyretic Analgesics by Application (2021–2032)
 Figure 64. Global Antipyretic Analgesics Price (USD/Kg) by Application (2021–2032)
 Figure 65. Antipyretic Analgesics Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners